Updated Jul 16, 2026 · Last SEC filing 2025-11-26
ATAI Life Sciences N.V. (ATAI) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every ATAI SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001840904 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Apeiron Investment Group Ltd. | Insider | J — Other acquisition / disposition | 2.37M | — | — | SEC | |
| Apeiron Investment Group Ltd. | Insider | P — Open-market purchase | 8.68M | $2.19 | $19.00M | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for ATAI Life Sciences N.V. (ATAI). Updated in real time as new filings are submitted to the SEC.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ATAI insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live ATAI dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.